A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(17 sites)

China

Anhui Cancer Hospital, Hefei, Anhui

Beijing Cancer Hospital, Beijing, Beijing Municipality

Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing, Beijing Municipality

Fujian cancer hospital, Fuzhou, Fujian

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong

Guangxi Medical University Cancer Hospital, Nanning, Guangxi

Henan cancer hospital, Zhengzhou, Henan

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Xiangya Hospital Central South University, Changsha, Hunan

The Second Xiangya Hospital, Central South University, Changsha, Hunan

Hunan Cancer Hospital, Changsha, Hunan

Liaoning cancer hospital, Shenyang, Liaoning

Shanghai Oriental Hospital, Shanghai, Shanghai Municipality

West China Hospital of Sichuan University, Chengdu, Sichuan

Zhejiang Cancer Hospital, Hangzhou, Zhejiang